Thrombin activatable fibrinolysis inhibitor (TAFI) is not associated with fetal loss, a retrospective study

Thromb Res. 2009;123(3):511-4. doi: 10.1016/j.thromres.2008.02.014. Epub 2008 May 2.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Carrier Proteins / blood*
  • Cohort Studies
  • Embryo Loss / blood*
  • Embryo Loss / etiology*
  • Embryo Loss / genetics
  • Female
  • Fetal Death / blood*
  • Fetal Death / etiology*
  • Fetal Death / genetics
  • Humans
  • Middle Aged
  • Pregnancy
  • Pregnancy Complications, Hematologic / blood*
  • Pregnancy Complications, Hematologic / genetics
  • Retrospective Studies
  • Risk Factors
  • Thrombophilia / blood*
  • Thrombophilia / complications*
  • Thrombophilia / genetics
  • Venous Thromboembolism / blood
  • Venous Thromboembolism / complications
  • Venous Thromboembolism / genetics
  • Young Adult

Substances

  • Carrier Proteins
  • ZFYVE1 protein, human